Skip to search formSkip to main contentSkip to account menu

ramoplanin

Known as: 2-(((3alpha,5beta)-3-hydroxy-7,24-dioxocholan-24-yl)amino)-, (SP-4-2)-, ramoplanin [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

7 relations

Narrower (2)

A 16686MD 62198

Broader (2)

Anti-Bacterial AgentsDepsipeptides
Ramoplanin:Susc:Pt:Isolate:OrdQnRamoplanin:Susc:Pt:Isolate:OrdQn:Gradient stripRamoplanin:Susc:Pt:Isolate:OrdQn:MIC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Ambush of Clostridium difficile Spores by Ramoplanin: Activity in an In Vitro Model
ABSTRACT Clostridium difficile infection (CDI) is a gastrointestinal disease caused by C. difficile, a spore-forming bacterium… 
2011
2011
Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS.
A method has been developed and validated for the quantification of ramoplanin, a 2554 Da peptide antibiotic, in human dried… 
2007
2007
Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin.
Ramoplanin is a glycolipodepsipeptide antibiotic active against Gram-positive bacteria including vancomycin-resistant enterococci… 
2004
2004
Efficacy of Oral Ramoplanin for Inhibition of Intestinal Colonization by Vancomycin-Resistant Enterococci in Mice
ABSTRACT Ramoplanin is a glycolipodepsipeptide antibiotic with activity against gram-positive bacteria that is in clinical trials… 
1999
1999
UDP‐N‐acetylglucosamine:N‐acetylmuramoyl‐(pentapeptide) pyrophosphoryl undecaprenol N‐acetylglucosamine transferase from Escherichia coli: overproduction, solubilization, and purification
1997
1997
Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin
Analyses of the peptidoglycan nucleotide precursor contents of enterococci and staphylococci treated with ramoplanin, tunicamycin… 
1995
1995
In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
Vancomycin-resistant Enterococcus faecium (VREF) collected between July 1991 and February 1994 were tested in vitro against RP… 
1991
1991
In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
1990
1990
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
The minimum inhibitory concentrations (MICs) of different antibiotics were determined by a broth microdilution method for… 
1990
1990
Update on glycopeptide resistance in enterococci
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)